{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:27:57Z","timestamp":1790386077094,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.endinu.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:45:41Z","timestamp":1558719941000},"page":"534-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluaci\u00f3n de la efectividad de la terapia ISCI a largo plazo mediante el objetivo combinado de descenso de HbA1c y ausencia de hipoglucemia grave"],"prefix":"10.1016","volume":"66","author":[{"given":"Carmen","family":"Quir\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Conget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2019.03.009_bib0115","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endinu.2019.03.009_bib0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.endinu.2019.03.009_bib0125","unstructured":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2006;353:2213-24."},{"key":"10.1016\/j.endinu.2019.03.009_bib0130","doi-asserted-by":"crossref","unstructured":"The DCCT Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.endinu.2019.03.009_bib0135","doi-asserted-by":"crossref","unstructured":"The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968-83.","DOI":"10.2337\/diabetes.44.8.968"},{"key":"10.1016\/j.endinu.2019.03.009_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ecl.2017.10.012","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes mellitus: Implications of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study 30-year follow-up","volume":"47","author":"Subramanian","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.endinu.2019.03.009_bib0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: Updated data from the T1D exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endinu.2019.03.009_bib0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.endonu.2016.03.008","article-title":"Situaci\u00f3n cl\u00ednica de una cohorte de pacientes con diabetes tipo 1 m\u00e1s de 2 d\u00e9cadas despu\u00e9s del inicio. Resultados de un programa espec\u00edfico de seguimiento en una unidad de referencia","volume":"63","author":"Amor","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endinu.2019.03.009_bib0155","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes","volume":"57","author":"Cryer","year":"2008","journal-title":"Diabetes."},{"key":"10.1016\/j.endinu.2019.03.009_bib0160","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-2054","article-title":"Increased mortality of patients with diabetes reporting severe hypoglycemia","volume":"35","author":"McCoy","year":"2012","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endinu.2019.03.009_bib0165","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2337\/dc15-2418","article-title":"A population-based study of all cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with T1D","volume":"39","author":"Lu","year":"2016","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endinu.2019.03.009_bib0170","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez M, L\u00f3pez JJ, Castell C, Conget I. Hypoglycaemia and cardiovascular disease in type 1 diabetes. Results from the Catalan National Public Health registry on insulin pump therapy. Diabetes Res Clin Pract. 2012;96: e23-5.","DOI":"10.1016\/j.diabres.2012.01.014"},{"key":"10.1016\/j.endinu.2019.03.009_bib0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc14-0920","article-title":"Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: A cohort study","volume":"38","author":"Gim\u00e9nez","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endinu.2019.03.009_bib0180","article-title":"Is insulin pump therapy effective in type 1 diabetes?","author":"Pickup","year":"2018","journal-title":"Diabet Med."},{"key":"10.1016\/j.endinu.2019.03.009_bib0185","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/dme.13094","article-title":"Long-term outcome of insulin pump therapy: Reduction of hypoglycaemia and impact on glycaemic control","volume":"33","author":"Quir\u00f3s","year":"2016","journal-title":"Diabet Med."},{"key":"10.1016\/j.endinu.2019.03.009_bib0190","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/dme.12869","article-title":"Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with type 1 diabetes","volume":"32","author":"Beato-V\u00edbora","year":"2015","journal-title":"Diabet Med."},{"key":"10.1016\/j.endinu.2019.03.009_bib0195","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00125-010-1706-z","article-title":"The shape of the metabolic memory of HbA1c: Re-analysing the DCCT with respect to time-dependent effects","volume":"53","author":"Lind","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.endinu.2019.03.009_bib0200","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/dc15-2399","article-title":"Mortality in type 1 diabetes in the DCCT\/EDIC versus the general population","volume":"39","author":"Lochin","year":"2016","journal-title":"Diabetes Care."},{"key":"10.1016\/j.endinu.2019.03.009_bib0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-017-0206-4","article-title":"Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: A multicenter study","volume":"9","author":"Bahia","year":"2017","journal-title":"Diabetol Metab Syndr."},{"key":"10.1016\/j.endinu.2019.03.009_bib0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMra1215228","article-title":"Mechanisms of hypoglycemia-associated autonomic failure in diabetes","volume":"369","author":"Cryer","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endinu.2019.03.009_bib0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.2014.16107","article-title":"Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality","volume":"313","author":"Orchard","year":"2015","journal-title":"JAMA."},{"key":"10.1016\/j.endinu.2019.03.009_bib0220","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2337\/dc16-1741","article-title":"Individualized glycemic goals and an expanded classification of severe hypoglycemia in diabetes","volume":"40","author":"Cryer","year":"2017","journal-title":"Diabetes Care."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419301053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419301053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:06:06Z","timestamp":1762866366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016419301053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2530016419301053"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2019.03.009","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n de la efectividad de la terapia ISCI a largo plazo mediante el objetivo combinado de descenso de HbA1c y ausencia de hipoglucemia grave","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}